Bacteriophages
İpek Kurtböke A , Nina Chanishvili B and Jeremy J Barr CA University of the Sunshine Coast, School of Science and Engineering and the GeneCology Research Centre, Maroochydore DC, Qld 4558, Australia
B Eliava Institute, Gotua Street 3, 0160, Tbilisi, Georgia
C School of Biological Sciences, Monash University, Clayton, Vic. 3800, Australia
Microbiology Australia 40(1) 3-4 https://doi.org/10.1071/MA19002
Published: 13 March 2019
Abstract
In order to avoid a return to the pre-antibiotic era, alternative treatments to combat microbial diseases are urgently needed. In this context, bacteriophages, which have been used effectively in distant parts of the world during the cold war era, are now gaining significant interest in the West. This special issue of the Microbiology Australia thus focusses on bacteriophages with contributions from Australia and from the members of the Expert round table on acceptance and re-implementation of bacteriophage therapy.
References
[1] Chanishvili, N. and Sharp, R. (2008) Bacteriophage Therapy: Experience from the Eliava Institute, Georgia. Microbiol. Aust. 29, 96–101.[2] Expert Round Table on Acceptance and Re‐Implementation of Bacteriophage Therapy (2016) Silk route to the acceptance and re‐implementation of bacteriophage therapy. Biotechnol. J. 11, 595–600.
| Silk route to the acceptance and re‐implementation of bacteriophage therapy.Crossref | GoogleScholarGoogle Scholar | 27008250PubMed |
[3] Sybesma, W. et al. (2018) Silk route to the acceptance and re-implementation of bacteriophage therapy—Part II. Antibiotics (Basel) 7, 35.
| Silk route to the acceptance and re-implementation of bacteriophage therapy—Part II.Crossref | GoogleScholarGoogle Scholar |
[4] Aminov, R. et al. (2017) Application of bacteriophages. Microbiol. Aust. 38, 63–66.
